Friday, February 01, 2008

Antiparasitic Therapy Reduces Seizures in Neurocysticercosis. Part 2


More intracranial cystic lesions resolved in the albendazole abstract entity than in the medicine grouping.
Except for abdominal pain, adverse effects were similar in both groups.

“In patients with seizures due to viable parenchymal cysts,
antiparasitic therapy decreases the signification of parasites and is
safe and effective, at least in reaction the periodical of seizures
with carry-over,” the authors write, noting that enlarging cysts may
venture intracranial hypertension. “Not to undertake antiparasitic
therapy in such cases could allow disease series and even risk the
patient’s life.
An additional, and commonly neglected, convex shape of communicating is
that most patients feel highly uncomfortable leaving a organism people
in their knowledge.”

The
Food and Drug Term of office, the National Institute of Allergy and
Infectious Diseases, and SmithKline Beecham supported this reflexion.

In
an accompanying editorial, Julio Sotelo, MD, from the National
Institute of Medical science and Neurosurgery in Mexico City, Mexico,
notes that praziquantel and albendazole are effective for destroying
brainpower cysticerci, have minimal perniciousness, and are inexpensive
and therefore practical because most infected patients are in lower
economic strata.

Dr.
Sotelo recommends studies with longer follow-up periods but concludes
that “the expeditious analysis of parasites is beneficial, and
cysticidal management should be administered to all patients with
mortal parenchymal neurocysticercosis.”



This is a part of article Antiparasitic Therapy Reduces Seizures in Neurocysticercosis. Part 2 Taken from "Albendazole (Generic Albenza) Information" Information Blog

No comments: